Arnsten, Amy F T
Article History
Received: 17 April 2015
Accepted: 15 July 2015
First Online: 25 September 2015
Competing interests
: A.F.T.A. and Yale University receive royalties from Shire Pharmaceuticals from the sales of Intuniv (extended release guanfacine) for the treatment of pediatric ADHD. They do not receive royalties from generic forms of Intuniv.